Recent

% | $
Quotes you view appear here for quick access.

Discovery Laboratories Inc. Message Board

oldpapa96 4 posts  |  Last Activity: May 19, 2015 8:50 PM Member since: Sep 23, 2011
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Ridgeback's A$15m investment in Prima will be made in two parts:

    On 05.14.15 Co. hands over %5 for approximately A$1.25m of Prima's issued shares which means that with today's outstanding shares of 40 million it would value the Co. at MC of $20M, but with the current crazy pump 40M x $2.50 = $100M !!!! So why wouldn't Prima sell shares on the market right now and solve all its' financing problems for years to come? Are they stupid or criminal pumpers are? Just asking ....ask yourself too!

  • Reply to

    Every victory counts

    by dlp3350 Apr 29, 2015 9:15 AM
    oldpapa96 oldpapa96 Apr 29, 2015 10:18 AM Flag

    actually this a big win for ROSG because it held back a long awaited licensing deals in Europe utilizing this patent. Berlin spoke about it very loudly when the initial patent was granted.

  • Reply to

    Contingency

    by alsense Apr 9, 2015 9:42 PM
    oldpapa96 oldpapa96 Apr 13, 2015 9:00 AM Flag

    I share your impatience and exasperation, while the Co. is definitely taking a dramatic turn to an aggressive growth, the stock remains badly broken, beloved "sell the news" game of the street. So sad and unfair.

  • Reply to

    Contingency

    by alsense Apr 9, 2015 9:42 PM
    oldpapa96 oldpapa96 Apr 11, 2015 8:12 PM Flag

    ****** In any event, the deal does seem like it will be accretive to earnings in the long run.*****
    So what would you attribute the projected 5 fold increase in revenue to $10-$12M in 2015 vs $2.5M gross billings in whole 2014, to a sudden organic growth? Even in the best case scenario of an exceptional success of thyroid test scheduled for Q3 the revenue and other collaborative products such a jump would be hardly imaginable. So this purchase must be highly accretive even in the short run even after taking into account additional general expenses and other associated overhead. Just wonder what is the logic behind your bitter claim?

DSCO
0.70+0.03(+4.48%)Jul 2 4:00 PMEDT